Zealand Pharma
900 DKK -1.37%11 investors are following this company
Zealand Pharma is a biotechnology company. Particular focus is found in the development of drugs for the treatment of diabetes and various intestinal diseases. The company has a varied product portfolio with separate brands that are sold on a global level. The largest business is in the Nordic market. Zealand Pharma was founded in 1997 and is headquartered in Söborg, Denmark.
Revenue
342.79M
EBIT %
-166.94 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Copenhagen
ZEAL
Daily low / high price
891 / 929
DKK
Market cap
63.9B DKK
Turnover
331.57M DKK
Volume
365K
Latest videos
Financial calendar
Interim report
15.08.2024
Interim report
07.11.2024
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Van Herk Investments | 16.8 % | 16.8 % |
Credit Suisse Group AG | 6.2 % | 6.2 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Total number of shares and voting rights in Zealand Pharma at June 28, 2024
Zealand Pharma completes registration of capital increase
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Zealand Pharma announces completion of an upsized equity offering of 8.35 million new ordinary shares raising gross proceeds of USD 1 billion / DKK 7 billion
Zealand Pharma announces upsizing of previously announced equity offering from approximately USD 900 million / DKK 6.257 billion to USD 1 billion / DKK 7 billion
Zealand Pharma launches equity offering of new shares raising gross proceeds of approximately USD 900 million / DKK 6.257 billion
![Aktier i vælten: Zealand Pharma - hvorfor så kraftig en reaktion på tidlige data?](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/e68a2474-de22-4af4-bee5-779f8c63a800.png)